CN201389127Y - Carbon fiber plaster application - Google Patents
Carbon fiber plaster application Download PDFInfo
- Publication number
- CN201389127Y CN201389127Y CN200920117401U CN200920117401U CN201389127Y CN 201389127 Y CN201389127 Y CN 201389127Y CN 200920117401 U CN200920117401 U CN 200920117401U CN 200920117401 U CN200920117401 U CN 200920117401U CN 201389127 Y CN201389127 Y CN 201389127Y
- Authority
- CN
- China
- Prior art keywords
- carbon fiber
- plaster
- woven fabrics
- medical
- basic unit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229920000049 Carbon (fiber) Polymers 0.000 title claims abstract description 32
- 239000004917 carbon fiber Substances 0.000 title claims abstract description 32
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 title claims abstract description 32
- 239000011505 plaster Substances 0.000 title claims abstract description 23
- 239000002674 ointment Substances 0.000 claims description 18
- 239000010410 layer Substances 0.000 claims description 17
- 239000004745 nonwoven fabric Substances 0.000 claims description 14
- 239000012790 adhesive layer Substances 0.000 claims description 3
- 206010052428 Wound Diseases 0.000 abstract description 16
- 208000027418 Wounds and injury Diseases 0.000 abstract description 16
- 210000002747 omentum Anatomy 0.000 abstract 2
- 230000000694 effects Effects 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 230000017423 tissue regeneration Effects 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000000955 neuroendocrine Effects 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 241000521257 Hydrops Species 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 241001464837 Viridiplantae Species 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 238000000586 desensitisation Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004880 lymph fluid Anatomy 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Abstract
The utility model relates to a carbon fiber plaster application, which comprises a carbon fiber layer, and is characterized in that medical omentum and parting paper are orderly covered on the carbon fiber layer, the designing of the medical omentum enables the carbon fiber plaster application to be more conveniently used, the designing of the parting paper prevents the unused carbon fiber plaster application from being polluted, furthermore, the carbon fiber plaster application can be made into various standards according with the sizes of wounds according to actual needs, and the use is convenient.
Description
Technical field
This utility model relates to carbon fiber and applies ointment or plaster.
Background technology
What medical application was mainly used in the human body wound surface protects wound, moisture absorption and fixing, and it generally includes gauze layer and is coated in the drug of topical application on the gauze layer.For example Chinese utility model patent ZL99243352.5 (notification number is CN2393547Y) disclosed " stype " promptly is a kind of simple medical application.This stype is made up of carbon fiber layer and the dressing layer that applies on it, and this stype need use according to the cutting of wound size in use.This stype is simple in structure, and the drug of topical application temporarily can be used.But this stype needs cutting in use, and what can pollute stype to be used for this, and using simultaneously neither be very convenient.
Summary of the invention
Technical problem to be solved in the utility model is that the present situation at prior art provides a kind of carbon fiber easy to use, health to apply ointment or plaster.
This utility model solves the problems of the technologies described above the technical scheme that is adopted: this carbon fiber is applied ointment or plaster, and comprises carbon fiber layer, it is characterized in that: be coated with medical nethike embrane and release paper on the described carbon fiber layer successively.
The design of medical nethike embrane makes this carbon fiber apply ointment or plaster and uses health more; And the design of release paper is then protected untapped carbon fiber to apply ointment or plaster and is made it not contaminated; And this carbon fiber is applied ointment or plaster and can be made into all size that meets the wound size according to actual needs, the convenient use.
Described carbon fiber layer can be laid in the pressure-sensitive non-woven fabrics basic unit.
Can be coated with adhesive-layer in the described pressure-sensitive non-woven fabrics basic unit, described carbon fiber layer sticks in the non-woven fabrics basic unit, and the edge of described release paper is pasted and fixed in the non-woven fabrics basic unit, and remainder covers medical nethike embrane.
Preferably, described release paper can be divided into left and right two, and its middle part part is superimposed, and when using carbon fiber to apply ointment or plaster, this structure makes things convenient for tearing of release paper.
Compared with prior art, this utility model is owing to be provided with medical nethike embrane and release paper, makes this carbon fiber health more of applying ointment or plaster, and easy to use.
Description of drawings
Fig. 1 is the perspective view of this utility model embodiment.
The specific embodiment
Embodiment describes in further detail this utility model below in conjunction with accompanying drawing.
As shown in Figure 1, this carbon fiber is applied ointment or plaster and is comprised pressure-sensitive non-woven fabrics basic unit 4, is coated with adhesive-layer in the pressure-sensitive non-woven fabrics basic unit 4, and acf layer 3 sticks on the middle part of pressure-sensitive non-woven fabrics basic unit 4, and medical nethike embrane 2 covers on the acf layer 3; Release paper 1 has left and right two, and left and right two edge sticks on the edge of pressure-sensitive non-woven fabrics basic unit 4 respectively, and the remainder of release paper 1 covers medical nethike embrane 2, and part is superimposed together.
During use, earlier left and right two release paper 1 are separated, torn from the centre, then acf layer 3 is aimed at wounds, pressure-sensitive non-woven fabrics basic unit 4 edges are sticked on the wound skin on every side.
Wherein, above-mentioned carbon fiber layer can adopt the fully natural green plant, and gelatinous fibre etc. are heated through cremating, and steam activation is made.It contains a large amount of far infrareies and anion, and these two kinds of physical agent combineds effect have changed ionic ratio and content of elements in histiocyte and the body fluid in the physiological action that body produces; Interior some material molecule (as protein molecular, the hydrone) structure of body is changed; Strengthen the circulation of blood and lymph fluid; Change biomembrane, blood vessel, mucosa, the permeability of skin and its hetero-organization; Regulate the neuroendocrine function, strengthen cell and humoral immunization function; Regulate substance metabolism.The therapeutical effect of two kinds of physical agent common points: can promote the elimination of neuroendocrine dysfunction, the function of enhancing body or system's organ is improved skin histology nutrition, promotes tissue repair and regeneration, provide the resistance of part or whole body, antiinflammatory, detumescence, analgesia, spasmolytic, desensitization, convergence etc.The auxiliary material that carbon fiber is applied ointment or plaster: medical nethike embrane, pressure-sensitive non-woven fabrics, all has extremely strong permeability, low irritability, no cytotoxicity, no skin irritation, medical nethike embrane also plays anti-impervious liquid and flows backwards, and changes dressings and opens easily, and wound does not have pain, and do not destroy wound tissue, stop to infect again the effect that phenomenon takes place.
This utility model can also be made into according to the difference of NACF layer institute compress material:
The surgical operation special use is applied ointment or plaster: can protect isolation to surgical wound, and have extremely strong adsorption function and drainage and clean wound effect, the wound infection that a variety of causes is caused has good prophylactic-therapeutic effect.
The decubital ulcer special use is applied ointment or plaster: the characteristics in the decubital ulcer topical therapeutic: strong adsorptivity, absorption transudate and slough, and it is clean that the skin ulcer face is done; Improve blood circulation, strengthen local skin nutrition; Antiinflammatory, pain relieving, convergence; Promote the granulation growth, promote skin tissue recovering regeneration.
The burn and scald special use is applied ointment or plaster: the clinical practice characteristics: absorbability is strong, and drain is good, and it is clean that wound surface is done, and avoids the local hydrops that forms; The good barrier protective effect prevents breeding and the invasion of antibacterial on wound surface, prevents that wound surface is infected; Minimizing is oozed out, and alleviates blood plasma components and loses; Antiinflammatory, detumescence, convergence, hemostasis, analgesia promotes tissue repair regeneration; The sticking wound surface of product, minimizing to the damage of new epithelize, has also alleviated the pain stimulation to wound surface in the process of changing dressings; Compare through conventional Therapeutic Method, it is to I, and there is the good effect that promotes healing in II degree burn wound.
Or the like.
Claims (4)
1, carbon fiber is applied ointment or plaster, and comprises carbon fiber layer, it is characterized in that: be coated with medical nethike embrane and release paper on the described carbon fiber layer successively.
2, carbon fiber according to claim 1 is applied ointment or plaster, and it is characterized in that: described carbon fiber layer sticks in the pressure-sensitive non-woven fabrics basic unit.
3, carbon fiber according to claim 2 is applied ointment or plaster, it is characterized in that: be coated with adhesive-layer in the described pressure-sensitive non-woven fabrics basic unit, described carbon fiber layer sticks in the non-woven fabrics basic unit, and the edge of described release paper is pasted and fixed in the non-woven fabrics basic unit, and remainder covers medical nethike embrane.
4, carbon fiber according to claim 3 is applied ointment or plaster, and it is characterized in that: described release paper is divided into left and right two, and its middle part part is superimposed.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200920117401U CN201389127Y (en) | 2009-04-09 | 2009-04-09 | Carbon fiber plaster application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200920117401U CN201389127Y (en) | 2009-04-09 | 2009-04-09 | Carbon fiber plaster application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN201389127Y true CN201389127Y (en) | 2010-01-27 |
Family
ID=41595942
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200920117401U Expired - Fee Related CN201389127Y (en) | 2009-04-09 | 2009-04-09 | Carbon fiber plaster application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN201389127Y (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102379765A (en) * | 2011-09-23 | 2012-03-21 | 大连创达技术交易市场有限公司 | Novel manufacture method of carbon fiber medical thermal paste |
| CN105617441A (en) * | 2016-03-16 | 2016-06-01 | 腾科宝迪（厦门）生物科技有限公司 | Antibacterial graphene dressing |
-
2009
- 2009-04-09 CN CN200920117401U patent/CN201389127Y/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102379765A (en) * | 2011-09-23 | 2012-03-21 | 大连创达技术交易市场有限公司 | Novel manufacture method of carbon fiber medical thermal paste |
| CN105617441A (en) * | 2016-03-16 | 2016-06-01 | 腾科宝迪（厦门）生物科技有限公司 | Antibacterial graphene dressing |
| CN105617441B (en) * | 2016-03-16 | 2017-04-26 | 腾科宝迪（厦门）生物科技有限公司 | Antibacterial graphene dressing |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2726815C (en) | Negative pressure wound therapy device | |
| US20120046603A1 (en) | Hyperbaric dressing and method | |
| CN106390213A (en) | Multifunctional silica gel negative-pressure drainage device and manufacturing method thereof | |
| WO2010139926A1 (en) | Hyperbaric dressing and method of manufacturing | |
| CN205181612U (en) | Compound foam dressing | |
| US20050186260A1 (en) | Medicated gel foam and method of use | |
| CN201389127Y (en) | Carbon fiber plaster application | |
| CN104644785B (en) | The red dredging collateral patch of a kind of hydrophilic polymer gel layer and its river obtained | |
| CN203694152U (en) | Medicinal moxa roll patch | |
| CN112545756A (en) | Preparation method of medical ozone oil-silicone foam patch | |
| CN203885716U (en) | Self-adhesive alginate applying patch | |
| CN1178686C (en) | Ointment for wound healing | |
| CN208114705U (en) | A kind of activated carbon fibre dressing with pain-relieving functions | |
| CN204814420U (en) | Linear dressing of neurosurgery specialty | |
| CN211156688U (en) | Dressing device | |
| CN204909824U (en) | Antibiotic applying ointment or plaster of medical restoration that contains EGF | |
| CN204033612U (en) | The special sepage absorbent dressing of carcinous wound | |
| CN205359798U (en) | Woundplast that contains oxidized regenerated cellulose | |
| CN217409145U (en) | Special-shaped application | |
| CN102727466B (en) | Rheumatism ointment capable of being adhered on surface of wound skin | |
| CN209678823U (en) | It is a kind of to treat cold compress patch | |
| CN212592711U (en) | Alginate sterile plaster for venous wound | |
| CN219323711U (en) | Wound application | |
| CN115721674B (en) | Composition for wound care and application thereof | |
| CN202235923U (en) | Medical application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: NINGBO BOSHENG MEDICAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: ZHOU RUYI Effective date: 20110418 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 315700 NINGBO BOSHENG MEDICAL TECHNOLOGY CO., LTD., NO. 305, PENGLAI ROAD, MODEL INDUSTRIAL PARK, XIANGSHAN COUNTY, ZHEJIANG PROVINCE TO: 315700 NO. 305, PENGLAI ROAD, MODEL INDUSTRIAL PARK, XIANGSHAN COUNTY, ZHEJIANG PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20110418 Address after: 315700 No. 305, Penglai Road, Xiangshan industrial demonstration zone, Zhejiang Province Patentee after: Ningbo Bo Sheng Medical Technology Co., Ltd. Address before: 315700 Ningbo Bo Sheng medical science and Technology Co., Ltd., Penglai Road, Zhejiang Road, Xiangshan 305, China Patentee before: Zhou Ruyi |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100127 Termination date: 20170409 |